Advertisement
Research Article

Capture of MicroRNA–Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor Signaling

  • Ashish Lal equal contributor mail,

    equal contributor Contributed equally to this work with: Ashish Lal, Marshall P. Thomas, Gabriel Altschuler, Francisco Navarro

    lalas@mail.nih.gov (AL); lieberman@idi.harvard.edu (JL)

    Affiliations: Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Marshall P. Thomas equal contributor,

    equal contributor Contributed equally to this work with: Ashish Lal, Marshall P. Thomas, Gabriel Altschuler, Francisco Navarro

    Affiliations: Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Gabriel Altschuler equal contributor,

    equal contributor Contributed equally to this work with: Ashish Lal, Marshall P. Thomas, Gabriel Altschuler, Francisco Navarro

    Affiliation: Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Francisco Navarro equal contributor,

    equal contributor Contributed equally to this work with: Ashish Lal, Marshall P. Thomas, Gabriel Altschuler, Francisco Navarro

    Affiliations: Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Elizabeth O'Day,

    Affiliations: Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Xiao Ling Li,

    Affiliation: Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Carla Concepcion,

    Affiliation: Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

    X
  • Yoon-Chi Han,

    Affiliation: Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

    X
  • Jerome Thiery,

    Affiliations: Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Danielle K. Rajani,

    Affiliations: Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Aaron Deutsch,

    Affiliations: Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Oliver Hofmann,

    Affiliation: Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Andrea Ventura,

    Affiliation: Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

    X
  • Winston Hide,

    Affiliation: Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Judy Lieberman mail

    lalas@mail.nih.gov (AL); lieberman@idi.harvard.edu (JL)

    Affiliations: Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Published: November 10, 2011
  • DOI: 10.1371/journal.pgen.1002363

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.